List of Excipients in API mefloquine hydrochloride
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing mefloquine hydrochloride
Detailed excipient profiles for mefloquine hydrochloride
Excipient focus: CALCIUM ALGINATE
mefloquine hydrochloride drug variants containing CALCIUM ALGINATE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | mefloquine hydrochloride | 0054-0025 |
| >Company | >Ingredient | >NDC |
mefloquine hydrochloride drug variants not containing CALCIUM ALGINATE
Excipient focus: CELLULOSE, MICROCRYSTALLINE
mefloquine hydrochloride drug variants containing CELLULOSE, MICROCRYSTALLINE
mefloquine hydrochloride drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: COLLOIDAL SILICON DIOXIDE
mefloquine hydrochloride drug variants containing COLLOIDAL SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| HJ Harkins Company Inc | mefloquine hydrochloride | 52959-803 |
| >Company | >Ingredient | >NDC |
mefloquine hydrochloride drug variants not containing COLLOIDAL SILICON DIOXIDE
Excipient focus: CROSPOVIDONE
mefloquine hydrochloride drug variants containing CROSPOVIDONE
mefloquine hydrochloride drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
mefloquine hydrochloride drug variants containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | mefloquine hydrochloride | 54868-5434 |
| >Company | >Ingredient | >NDC |
mefloquine hydrochloride drug variants not containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
Excipient focus: LACTOSE MONOHYDRATE
mefloquine hydrochloride drug variants containing LACTOSE MONOHYDRATE
mefloquine hydrochloride drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
mefloquine hydrochloride drug variants containing MAGNESIUM STEARATE
mefloquine hydrochloride drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLOXAMER 124
mefloquine hydrochloride drug variants containing POLOXAMER 124
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | mefloquine hydrochloride | 21695-449 |
| >Company | >Ingredient | >NDC |
mefloquine hydrochloride drug variants not containing POLOXAMER 124
Excipient focus: POLOXAMER 188
mefloquine hydrochloride drug variants containing POLOXAMER 188
mefloquine hydrochloride drug variants not containing POLOXAMER 188
Excipient focus: POLOXAMER 331
mefloquine hydrochloride drug variants containing POLOXAMER 331
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | mefloquine hydrochloride | 0054-0025 |
| >Company | >Ingredient | >NDC |
mefloquine hydrochloride drug variants not containing POLOXAMER 331
Excipient focus: POLYSORBATE 80
mefloquine hydrochloride drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | mefloquine hydrochloride | 21695-561 |
| HJ Harkins Company Inc | mefloquine hydrochloride | 52959-803 |
| >Company | >Ingredient | >NDC |
mefloquine hydrochloride drug variants not containing POLYSORBATE 80
Excipient focus: POVIDONE K30
mefloquine hydrochloride drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | mefloquine hydrochloride | 0054-0025 |
| Rebel Distributors Corp | mefloquine hydrochloride | 21695-561 |
| HJ Harkins Company Inc | mefloquine hydrochloride | 52959-803 |
| >Company | >Ingredient | >NDC |
mefloquine hydrochloride drug variants not containing POVIDONE K30
Excipient focus: PROPYLENE GLYCOL ALGINATE
mefloquine hydrochloride drug variants containing PROPYLENE GLYCOL ALGINATE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | mefloquine hydrochloride | 0054-0025 |
| >Company | >Ingredient | >NDC |
mefloquine hydrochloride drug variants not containing PROPYLENE GLYCOL ALGINATE
Excipient focus: SILICON DIOXIDE
mefloquine hydrochloride drug variants containing SILICON DIOXIDE
mefloquine hydrochloride drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| HJ Harkins Company Inc | mefloquine hydrochloride | 52959-803 |
| Physicians Total Care Inc | mefloquine hydrochloride | 54868-5434 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
mefloquine hydrochloride drug variants containing STARCH, CORN
mefloquine hydrochloride drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
mefloquine hydrochloride drug variants containing TALC
mefloquine hydrochloride drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | mefloquine hydrochloride | 0054-0025 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
